Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP17A1 | P05093 | 2/20 | 0.44 |
| ▸ | KAT6A | Q92794 | 1/20 | 0.43 |
| ▸ | CA12 | O43570 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA9 | Q16790 | 1/20 | 0.41 |
| ▸ | NAMPT | P43490 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 3/20 | 0.40 |
| ▸ | RAB9A | P51151 | 3/20 | 0.40 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.40 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.40 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.40 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.40 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.40 |
| ▸ | PRMT3 | O60678 | 1/20 | 0.40 |
| ▸ | PLAU | P00749 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | MLYCD | O95822 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | LEF1 | Q9UJU2 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8739566 | 0.87 | CYP17A1 (0.49) | CYP17A1CA12CA1CA9NAMPT | |
| SCHEMBL8109929 | 0.85 | HDAC3 (0.55) | CYP17A1KAT6ACA12CA1CA9 | |
| SCHEMBL3563135 | 0.83 | PTPN11 (0.54) | CYP17A1KAT6ACA12CA1CA9 | |
| SCHEMBL6113073 | 0.81 | KAT6A (0.48) | CYP17A1KAT6ACA12CA1CA9 | |
| SCHEMBL4672586 | 0.80 | NPC1 (0.50) | KAT6ACA12CA1CA9NPC1 | |
| SCHEMBL6125423 | 0.80 | KAT6A (0.43) | CYP17A1KAT6ACA12CA1CA9 | |
| SCHEMBL3564415 | 0.79 | ALDH1A1 (0.51) | CYP17A1KAT6ACA12CA1CA9 | |
| SCHEMBL6113230 | 0.79 | MAPT (0.46) | CYP17A1KAT6ACA12CA1CA9 | |
| SCHEMBL3567785 | 0.79 | CYP17A1 (0.49) | CYP17A1KAT6ACA12CA1CA9 | |
| SCHEMBL9102483 | 0.79 | MLYCD (0.40) | CYP17A1CA12CA1CA9HDAC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9006458-B2 | Surface Enhanced Raman Spectroscopy (SERS) compounds and methods of their preparation | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2015-04-14 | — | — | US | disclosed |
| US-9006458-B2 | Surface Enhanced Raman Spectroscopy (SERS) compounds and methods of their preparation | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2015-04-14 | — | — | US | disclosed |
| US-20120128592-A1 | SURFACE ENHANCED RAMAN SPECTROSCOPY (SERS) COMPOUNDS AND METHODS OF THEIR PREPARATION | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2012-05-24 | — | — | US | disclosed |
| US-20120128592-A1 | SURFACE ENHANCED RAMAN SPECTROSCOPY (SERS) COMPOUNDS AND METHODS OF THEIR PREPARATION | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2012-05-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120128592-A1 | SURFACE ENHANCED RAMAN SPECTROSCOPY (SERS) COMPOUNDS AND METHODS OF THEIR PREPARATION | NR1I2, SPR, NR1H4 | CYP17A1 211/4885KAT6A 3865/4885CA12 796/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.